Insulin Dysregulation

• Insulin Resistance
  Common in type 2 diabetes and metabolic syndrome.
  Cells become less responsive to insulin, leading to increased secretion.
• Hyperinsulinemia
  Can result from excess exogenous insulin administration.
  Also linked to high carbohydrate intake and obesity.
• Early Phase of Type 2 Diabetes
  Pancreatic beta-cells overcompensate, producing excess insulin due to insulin resistance.

‍

Low Insulin Production and Its Causes

• Type 1 Diabetes Mellitus
  Autoimmune destruction of pancreatic beta cells results in very low or absent endogenous insulin production.
• Pancreatic Damage
  Conditions such as pancreatitis or surgical resection can reduce insulin output.

‍

Insulin Considerations Across Life Stages

• Pediatric Populations
  Type 1 diabetes often emerges in childhood or adolescence, necessitating prompt insulin replacement.
• Adults
  In type 2 diabetes, high insulin levels and insulin resistance are common.
  Over time, beta-cell failure can lead to declining insulin levels.
• Elderly
  Changes in insulin sensitivity and pancreatic function require careful management.
  Balancing hyperglycemia and hypoglycemia is crucial for optimal health.

‍

Glucose Metabolic Markers and Regulators

• Blood Sugar & Glucose in Plasma:
  Both reflect the current level of sugar circulating in the bloodstream. These are the central metrics for assessing glycemic status and are directly influenced by various hormonal signals.
  
  
• Insulin:
  This hormone, secreted by pancreatic beta cells, lowers Blood Sugar and Glucose in Plasma by facilitating the uptake of glucose into cells. It is key in maintaining normal glycemic levels.
  
  
• Glucagon:
  Secreted by pancreatic alpha cells, Glucagon acts in opposition to Insulin by stimulating the liver to release stored glucose, thereby increasing Blood Sugar during fasting or low-glucose conditions.
  
  
• Glycosylated Hemoglobin (HbA1c):
  This marker measures the non-enzymatic attachment of glucose to hemoglobin over approximately two to three months, providing a long-term view of Blood Sugar control.
  
  
• Somatotropic Hormone (Growth Hormone, GH):
  This hormone influences metabolism by reducing the sensitivity of tissues to Insulin, indirectly contributing to higher Blood Sugar levels. It also plays a role in growth and overall energy balance.
  
  
• Serotonin:
  Although primarily known as a neurotransmitter, Serotonin also modulates Insulin secretion and energy balance, indirectly affecting Blood Sugar regulation.
  
  

These markers are interrelated elements of the body’s glucose metabolic and endocrine network. Blood Sugar and Glucose in Plasma provide the primary measure of glycemic status, controlled by the opposing actions of Insulin and Glucagon. Glycosylated Hemoglobin (HbA1c) offers insight into long-term glucose management, while Somatotropic Hormone (Growth Hormone, GH) and Serotonin modulate metabolic processes that influence overall blood sugar levels.

‍